BioMed Research International

Novel Non-Invasive Biomarkers for the Diagnosis and Management of Celiac Disease


Publishing date
01 Mar 2022
Status
Closed
Submission deadline
12 Nov 2021

Lead Editor

1Università Politecnica delle Marche, Ancona, Italy

2All India Institute of Medical Sciences, New Delhi, India

3Federal University of Goiás (UFG), Goiânia, Brazil

This issue is now closed for submissions.
More articles will be published in the near future.

Novel Non-Invasive Biomarkers for the Diagnosis and Management of Celiac Disease

This issue is now closed for submissions.
More articles will be published in the near future.

Description

Celiac disease (CD) is characterized by villous atrophy and affects approximately 1-2% of the global population. A confirmatory diagnosis of CD requires a sequence of duodenal biopsies confirming the actual status of villous abnormality. However, obtaining biopsies is an invasive and expensive diagnostic procedure.

Multiple celiac-specific non-invasive serological markers have been established but they do not predict the actual status of the villous architecture. Furthermore, their finding is highly non-specific and requires validation from duodenal biopsy examination. To date, a reliable non-invasive marker for assessing villous atrophy is still not well-established. Therefore, there is an immense need for a trusted, non-invasive, affordable, and easy to perform examination for assessing the celiac-specific histological structure. Certain recently-adopted biomarkers such as citrulline and Intestinal fatty acid binding proteins (I-FABP) could be quite promising to predict villous abnormalities, however, none are proven as a reliable test for the diagnosis and management of CD and therefore require further validation before their inclusion in clinical practice. Novel developing approaches like transcriptomics, proteomics, and genomics could be used alone or in combination with other factors for the diagnosis, treatment, and monitoring of this disease. However, their efficacy is still under investigation.

This Special Issue aims to provide a comprehensive collection of articles describing current approaches to accurately assessing the status of villous abnormalities through minimally invasive or non-invasive methods that can be established as a fair replacement for the complex, expensive, and invasive duodenal biopsy procedure. Original research and review articles are welcome.

Potential topics include but are not limited to the following:

  • Novel evolving biomarkers for CD screening
  • Biomarkers of gut barrier function
  • Biomarkers to detect gluten adherence
  • Biomarkers for celiac management
  • Biomarkers for non-celiac gluten sensitivity
  • Biomarkers for gluten detection
  • Biomarkers for other gluten-related disorders
  • Biomarkers for leaky gut (zonulin)
  • Biomarkers for HLA-DQ alleles
  • Biomarkers to detect endomysial antibody (EMA)
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore4.100
Journal Citation Indicator0.610
Impact Factor3.411
 Submit

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.